208000002098 Purpura, Thrombocytopenic, Idiopathic Diseases 0.000 claims description 16.201000000498 stomach carcinoma Diseases 0.000 claims description 17.206010017758 Gastric cancer Diseases 0.000 claims description 18.201000005249 lung adenocarcinoma Diseases 0.000 claims description 19.208000010507 Adenocarcinoma of Lung Diseases 0.000 claims description 19.231100000844 hepatocellular carcinoma Toxicity 0.000 claims description 20.206010073071 Hepatocellular carcinoma Diseases 0.000 claims description 21.201000008275 breast carcinoma Diseases 0.000 claims description 23.206010006187 Breast cancer Diseases 0.000 claims description 25.229920001850 Nucleic acid sequence Polymers 0.000 claims description 28.201000005161 thyroid carcinoma Diseases 0.000 claims description 32.201000002510 thyroid cancer Diseases 0.000 claims description 33.230000002018 overexpression Effects 0.000 claims description 36.206010060862 Prostate cancer Diseases 0.000 claims description 37.201000010174 renal carcinoma Diseases 0.000 claims description 62.
206010038389 Renal cancer Diseases 0.000 claims description 64.201000010240 chromophobe renal cell carcinoma Diseases 0.000 claims description 116.239000002773 nucleotide Substances 0.000 claims abstract description 50.125000003729 nucleotide group Chemical group 0.000 claims abstract description 51.201000010099 disease Diseases 0.000 claims abstract description 166.230000014509 gene expression Effects 0.000 claims abstract description 182.238000010354 CRISPR gene editing Methods 0.000 claims abstract description 300.238000007374 clinical diagnostic method Methods 0.000 title description 3.241000282414 Homo sapiens Species 0.000 title claims abstract description 238.229920000033 CRISPR Polymers 0.000 title claims abstract description 395.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to NLPCT/NL2016/050873 priority Critical Priority to NL2016050873 priority Application filed by Erasmus University Medical Center Rotterdam filed Critical Erasmus University Medical Center Rotterdam Publication of WO2018111104A1 publication Critical patent/WO2018111104A1/en Links Inventor Rogier Petrus Leonardus LOUWEN Petrus Johannes Van Der Spek Chinmoy SAHA Original Assignee Erasmus University Medical Center Rotterdam Priority date (The priority date is an assumption and is not a legal conclusion. Google Patents WO2018111104A1 - Use of human crispr sequences in diagnostics WO2018111104A1 - Use of human crispr sequences in diagnostics
0 kommentar(er)
